Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Penn State University
University of Florida
Essen Biotech
Essen Biotech
University of Salamanca
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Baylor College of Medicine
University of Colorado, Denver
Washington University School of Medicine
Washington University School of Medicine
University of Michigan Rogel Cancer Center
Duke University
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
Stanford University
Cedars-Sinai Medical Center
OHSU Knight Cancer Institute
Cellestia Biotech AG
Eastern Cooperative Oncology Group
Mayo Clinic
Duke University
Scripps Health
Blue Note Therapeutics
Novartis
The University of Texas Health Science Center, Houston
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Celgene
University of Wisconsin, Madison
Chinese PLA General Hospital
AbbVie
Novartis
City of Hope Medical Center
Incyte Corporation
Henry Ford Health System
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
Michigan State University
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute